Intravascular Ultrasound System Market - By Product Type: IVUS Consoles, IVUS Catheters; By Application: Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD); By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers (ASCs), By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global intravascular ultrasound (IVUS) system market is gaining significant traction due to the rising burden of cardiovascular disease and the increasing demand for real-time vessel visualization during interventional procedures. IVUS enables cross-sectional imaging of coronary and peripheral arteries, facilitating precise assessment of plaque morphology, vessel size, and stent placement.
The technology is increasingly being integrated into catheterization labs, driven by its ability to improve percutaneous coronary intervention (PCI) outcomes. Newer catheter designs, digital consoles, and integration with AI-guided planning tools are expanding clinical adoption across developed and emerging healthcare systems.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
0.51 |
Baseline usage in coronary interventions |
|
2024 |
0.88 |
Five-year CAGR 11.5% |
|
2031 |
1.91 |
Seven-year CAGR 11.8% |
The market is projected to more than double by 2031, driven by clinical accuracy demands, technological integration, and global cardiovascular care expansion.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The IVUS system market is dominated by key cardiovascular device companies offering catheter-console integration, high-frequency transducers, and AI-powered image processing.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Boston Scientific |
45% |
OptiCross™, iLab™ and Polaris™ IVUS platforms |
|
Philips Volcano |
38% |
Eagle Eye™ Platinum, Core Precision™, SyncVision™ platform |
|
Terumo Corporation |
9% |
AltaView™ IVUS catheter (Asia and Europe focus) |
|
Others (ACIST, Conavi, startups) |
8% |
Hybrid IVUS-OCT, micro-catheter innovations |
6 | Market Segmentation
By Product Type:
By Application:
By End User:
By Region:
7 | Strategic Outlook
The future of IVUS will involve catheter-wire hybridization, AI-based lesion mapping, and remote training platforms. Wider clinical trial validation, integration with digital health records, and streamlined regulatory approvals will support adoption in mid-tier global hospitals.
Need help?
Chat with our team in a minute.